HIV/AIDS Vaccine
Boost regimen induced HIV type 1-specific T cells
Published in AIDS Vaccine Week, January 9th, 2006
According to recent research from England, "In the absence of strategies for reliable induction of antibodies broadly neutralizing human immunodeficiency virus type 1 (HIV-1), vaccine efforts have shifted toward the induction of cell-mediated immunity. We describe the construction and immunogenicity of novel T-cell vaccine NS1.HIVA, which delivers the HIV-1 clade A consensus-derived immunogen HIVA on the surface of tubular structures spontaneously formed by protein NS1 of bluetongue virus."
"We demonstrated that NS1 tubules can accommodate a protein as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Vaccine Week
Source: AIDS Vaccine Week (2006-01-09)
More Articles from AIDS Vaccine Week
- HIV/AIDS Vaccine
Adenoviruses encoding HIV Tat and SIV Gag enhanced cellular immunity to SIV Gag - HIV/AIDS Vaccine
HIV-1 Gag dimerization-induced assembly involves multi-step pathway - Diagnostics
HIV-associated cardiomyopathy can be detected early and may be effectively treated - Disease Control
High morbidity continues to be associated with diarrheal diseases - Feline Immunodeficiency Virus Therapy
Neutralizing Abs inactivate rHuG-CSF in FIV-infected cats on long-term therapy - HIV/AIDS Adverse Drug Reaction
CNS toxicity associated with increased efavirenz plasma levels in HIV/AIDS - More from this issue of AIDS Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
